Prostate cancer
Showing 9976 - 10000 of >10,000
Cervical Cancer, HPV, HIV Trial (Elimisha HPV)
Not yet recruiting
- Cervical Cancer
- +3 more
- Elimisha HPV
- (no location specified)
Feb 8, 2023
From Lung and Blood Samples in Suspected Lung Cancer
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Bronchoscopic Biopsy
- Blood Sample
-
Farmington, Connecticut
- +4 more
Aug 17, 2022
Potential Clinical Utilities of Circulating Tumor DNA in
Not yet recruiting
- Gastric Cancer
- Circulating Tumor DNA (ctDNA)
- (no location specified)
Aug 21, 2022
Endometrial Serous Adenocarcinoma Trial in United States (Biospecimen Collection, Resection, Triapine)
Recruiting
- Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +2 more
-
Coral Gables, Florida
- +5 more
Aug 23, 2022
NSCLC Trial in Chendu (Almonertinib)
Recruiting
- Non-small Cell Lung Cancer
-
Chendu, Sichuan, ChinaWest China Hospital,Sichuan University
Dec 14, 2022
Lyme Borreliosis Trial in United States (VLA15, Placebo)
Active, not recruiting
- Lyme Borreliosis
- VLA15
- Placebo
-
Milford, Connecticut
- +4 more
Jul 6, 2021
Long Term Survivors of Ovarian Cancer
Active, not recruiting
- Ovarian Cancer
- Questionnaire
- Interview
-
West Hollywood, California
- +4 more
Aug 22, 2022
Developing a MRI-based Deep Learning Model to Predict MMR Status
Not yet recruiting
- Endometrial Cancer
- randomly divided
- (no location specified)
Mar 13, 2023
Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8 Trial in Duarte (Copper Cu
Recruiting
- Locally Advanced Rectal Carcinoma
- +4 more
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A
- Imaging Technique
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin
Active, not recruiting
- Breast Carcinoma
- +4 more
- Metformin Hydrochloride
- Doxycycline
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 28, 2022
Colon Cancer Trial in Daegu (timing to initiate the adjuvant chemo)
Active, not recruiting
- Colon Cancer
- timing to initiate the adjuvant chemotherapy
-
Daegu, Korea, Republic of
- +1 more
Dec 21, 2022
Esophageal Trial in Nanjing ("Endostar", Liposo, cisplatin)
Terminated
- Esophageal
- "Endostar"
- +3 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jul 28, 2022
Intraoperative Flow Cytometry In Colorectal Cancer
Completed
- Colorectal Cancer
- flow cytometry
-
Ioannina, Epirus, GreeceUniversity Hospital of Ioannina
Feb 18, 2022
Remote Breast Cancer Screening Study
Recruiting
- Breast Cancer
- +4 more
- Conventional-reading
- +4 more
-
Xi'an, Shaanxi, China
- +1 more
Aug 14, 2022
Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)
Active, not recruiting
- Stomach Neoplasms
- +2 more
- Atezolizumab
- +3 more
-
Beijing, China
- +10 more
Dec 21, 2022
Urinary Bladder Tumors Trial in Worldwide (Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy
Recruiting
- Urinary Bladder Neoplasms
- Pembrolizumab
- +8 more
-
Washington, District of Columbia
- +120 more
Jan 19, 2023
Breast Cancer, Brain Metastases Trial in United States (Whole Brain Radiotherapy (WBRT), Sorafenib)
Completed
- Breast Cancer
- Brain Metastases
- Whole Brain Radiotherapy (WBRT)
- Sorafenib
-
Basking Ridge, New Jersey
- +5 more
Mar 4, 2022
First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)
Not yet recruiting
- First-line Treatment of Non-clear Renal Cell Carcinoma
- Fruquintinib combined with Serplulimab
- (no location specified)
Apr 16, 2023
Stage IV NSCLC, Targeted Therapy, Nonsmall Cell Lung Cancer Trial in Boston (POISE)
Not yet recruiting
- Stage IV Non-small Cell Lung Cancer
- +7 more
- POISE
-
Boston, MassachusettsMassachusetts General Hospital
Apr 13, 2022
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,
Active, not recruiting
- Acute Myeloid Leukemia
- +5 more
- Decitabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Ovarian Cancer Trial in Lexington (Artemisia annua 450mg, Artemisia annua 900mg, Artemisia annua 1350mg)
Recruiting
- Ovarian Cancer
- Artemisia annua 450mg
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Jan 4, 2023
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Gallbladder Adenocarcinoma Trial in Morgantown (HIPEC)
Not yet recruiting
- Gallbladder Adenocarcinoma
-
Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
Jun 23, 2022